MARKET REPORT: Drug-fixing scandal hits Alliance Pharma shares
Peter Butterfield, who has run the firm since 2018, is facing a competition disqualification order from the Competition and Markets Authority.
Source: thisismoney.co.uk
Stay updated with breaking news from Focus Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Peter Butterfield, who has run the firm since 2018, is facing a competition disqualification order from the Competition and Markets Authority.
Peter Butterfield, who has run the firm since 2018, is facing a competition disqualification order from the Competition and Markets Authority.
Investegate announcements from Oxford Cannabinoid, Requisition of General Meeting
The CMA is investigating alleged anti-competitive agreements in the pharmaceutical sector under Chapter I CA98 (case reference: 50511-2).